Medtronic Diabetes Pipeline Includes Insulin Patch, Next-Gen CGM
Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch
Medtronic is aiming to submit a 510(k) application to FDA for its patch-based insulin delivery device by year-end, setting the stage for a mid-2010 U.S. launch